BLADEX, INC.

BLX
About the company

Bladex Inc., a multinational bank, engages in financing of foreign trade and economic integration in Latin America and the Caribbean. It operates through Commercial and Treasury segments. The company accepts deposits.

Price: $50.55Market Cap: $1.9B

Investment snapshot

31%positive consensus
Scored 1d ago

Positive

5

BUY / PASS

Neutral / negative

6 / 5

NEUTRAL / FAIL

Median fair value

$50.43

-0.2% vs price

Models with upside

3 / 16

Positive margin of safety

Strongest signal

6 of 8 pass — Lynch and Neff object

Key risk

11 of 12 flag BLX's valuation — Lynch, Dreman, Munger +8 more

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictBUYFAILFAILPASSPASSNEUTRALFAILPASSNEUTRALNEUTRALNEUTRALPASSNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/A+37.3%N/AN/A+4.9%N/A+12.2%-6.0%-53.8%N/A-30.8%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Market data at 2026-11-01

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Market data at 2026-11-01

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-01-01–2026-11-01

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Qualitative assessment

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-01-01–2026-11-01

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Annual history · FY 2024 · Price history 2025-01-01–2026-11-01

Latest source filing: 2025-04-15

Score computed: 2026-11-14

Where It Passes

  • Growth75% pass✓ 10✗ 2▾

    6 of 8 pass — Lynch and Neff object

    EPS Growth (3-yr avg, 10-yr window)167.5%
    ✓Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR74.7%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    EPS Growth Direction$1.50 (2009) -> $4.55 (2023)
    ✓DremanPositive over recent years
    EPS CAGR8.2% CAGR over 14 years
    ✓Dreman> 5% annualized
    Positive Net Income Frequency16/16 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth59.7%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency3/4 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR20.3% CAGR over 4 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 100.0% -> 100.0%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR19.1%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR74.7% over 5 years
    ✗Neff7%-20% annualized

Where It Falls Short

  • Valuation8% pass✓ 8✗ 18▾

    11 of 12 flag BLX's valuation — Lynch, Dreman, Munger +8 more

    Price / Book Value per Share1.4x
    ✓Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Price / 3-yr avg EPS14.3x
    ✓Graham<= 15x
    Price-to-Tangible-Book Ratio1.4x
    ✓Graham<= 1.5x
    P/E x P/TBV19.90
    ✓Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Tangible Book Value per Share1.4x
    ✗Dreman< 1.2x✗SchlossP/TBV <= 1.00x (app cutoff)
    Valuation Reasonableness
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=-6.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=1.4x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value4.9% (IV=$53.17 vs Price=$50.55)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low138% of trailing low ($36.60)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+10.94%; #572/6340 (top 9.0%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.7105; #2157/6449 (top 33.4%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Book Value per Share Change+41.6%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.1613; #3983/5247 (top 75.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-6.61%; #3069/4519 (top 67.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-7.01%; #3250/6202 (top 52.4%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow20% pass✓ 2✗ 10▾

    8 of 10 flag BLX's cash flow — Lynch, Piotroski, Dreman +5 more

    Free Cash Flow Proxy$109.3M
    ✓BuffettPositive and growing
    FCF Positive and Growing$-124.5M
    ✗LynchPositive and growing
    Operating Cash Flow$-122.7M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-1.03%, ROA=1.74%
    ✗PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=-6.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive11/16 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-6.7%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency11/16 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-124.5M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-6.61%; #3069/4519 (top 67.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Debt & Leverage25% pass✓ 1✗ 4▾

    3 of 4 flag BLX's debt & leverage — Templeton, Asness and Schloss

    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Total Debt / Shareholders' Equity3.25
    ✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Negative debt-to-equity (higher means less debt)-3.2548; #3950/4210 (top 93.8%)
    ✗AsnessTop 30% of eligible cross-section
    Current Assets / Current Liabilities
    ✗SchlossCurrent ratio >= 1.50x (app cutoff)
  • Efficiency33% pass✓ 1✗ 2▾

    2 of 3 flag BLX's efficiency — Akre and Sleep

    Revenue / Total Assets Change YoY0.02x -> 0.03x
    ✓PiotroskiImproved YoY
    Reinvestment Rate x ROIC10.0% (RR=65% x ROIC=15.4%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROE (5-year)2/5 years above 12% (latest 15.4%)
    ✗SleepROE > 12% in a majority of years
  • Profitability38% pass✓ 20✗ 15▾

    10 of 16 flag BLX's profitability — Graham, Buffett, Lynch +7 more

    Return on Equity15.4%
    ✓Munger> 15%✗AkreROE > 20% (3-year avg)
    Positive EPS (10 years)15/17 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)167.5%
    ✓Graham>= 33% growth
    Net Income Positive (10+ years)16/17 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)10.1%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)100.0% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$109.3M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)0.42
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR74.7%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE15.4%
    ✓Lynch> 15%
    Net Income / Total Assets1.74%
    ✓PiotroskiROA > 0
    ROA Change YoY1.55% -> 1.74% (delta: +0.19%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-1.03%, ROA=1.74%
    ✗PiotroskiCFO/Assets > ROA
    Pre-Tax Income / Revenue
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity15.4%
    ✓Dreman> 12%
    Margin of SafetyP/TBV=1.4x
    ✓PabraiP/TBV < 1.5 or P/E < 15
    ROE (high and growing)FY2022: ROE=8.6%; FY2023: ROE=13.8%; FY2024: ROE=15.4%
    ✗AkreLatest 3 consecutive FYs: ROE > 15% in each
    Discount to Intrinsic Value4.9% (IV=$53.17 vs Price=$50.55)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency16/16 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue100.0%
    ✓Ackman>= 15%
    Net Income / Shareholders Equity15.4%
    ✓Ackman>= 15%
    5-Year EPS CAGR20.3% CAGR over 4 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend100.0% (2022) -> 100.0% (2024)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 100.0% -> 100.0%
    ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
    ROE (5-year)2/5 years above 12% (latest 15.4%)
    ✗SleepROE > 12% in a majority of years
    Net income / market capitalization+10.94%; #572/6340 (top 9.0%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+15.40%; #1122/5226 (top 21.5%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0036; #382/5884 (top 6.5%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR74.7% over 5 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years9/9 years positive
    ✓Schloss>= 70% positive over 5-10 observed years (app rule)
  • Verdicts50% pass✓ 5✗ 5▾

    Split decision: 6 NEUTRAL · 5 FAIL · 4 PASS · 1 BUY

    Overall verdict
    ✓GrahamBUY (6/7)✗BuffettFAIL (1/6)✗LynchFAIL (2/4)✓PiotroskiPASS (F-Score 4)✓DremanPASS (5/9)•MungerNEUTRAL (2/3)✗PabraiFAIL (1/3)✓AkrePASS (2/5)•MarksNEUTRAL (3/4)•AckmanNEUTRAL (5/8)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
  • Valuation models50% pass✓ 3✗ 3▾

    Models split on BLX at $50.55 — fair values range $32.87–$80.68

    Buffett fair value$80.68
    ✓Buffett+37.3% margin vs $50.55
    Dreman fair value$53.17
    ✓Dreman+4.9% margin vs $50.55
    Pabrai fair value$57.56
    ✓Pabrai+12.2% margin vs $50.55
    Akre fair value$47.69
    ✗Akre-6.0% margin vs $50.55
    Marks fair value$32.87
    ✗Marks-53.8% margin vs $50.55
    Templeton fair value$38.66
    ✗Templeton-30.8% margin vs $50.55

Business & financials

Financial snapshot: annual FY 2024. Current investor scores may use newer quarterly data.

Company Profile

Industry: Banking
Size: Small Cap($1.9B)
Revenue: $303.6M+14.1% YoY
Net Income: $205.9M+23.9% YoY

Financial Snapshot

Operating Margin100.0%
Return on Equity15.4%
Debt / Equity3.25
Current Ratio--
Shares Retired−0.7% / −1.3% 2y

Similar Companies

MUFGMITSUBISHI UFJ FINANCIAL GROUP INC
$245.7B
AXPAMERICAN EXPRESS CO
$215.0B
SANBanco Santander, S.A.
$175.9B
ATMPBARCLAYS BANK PLC
$82.1B
Sector-adjusted criteria: Bank

Leverage is a bank’s business model and current accounts don’t exist on its balance sheet, so debt and liquidity tests are omitted and tangible book value and ROE replace their industrial analogs.

Shareholder Return

Fiscal 2024

Issued 0.7% of shares last year, 1.3% issued over two.

Buybacks
—
Dividends
$72.8M

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY21
1.2% = −1.4% + 2.7%
FY22
56.8% = 46.8% + 6.8%
FY23
79.1% = 80.5% + −0.8%
Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

MetricFY 2024
Sources
  • 20-F · 2025-04-15
FY 2023
Sources
  • 20-F · 2024-04-25
FY 2022
Sources
  • 20-F · 2023-04-28
FY 2021
Sources
  • 20-F · 2022-04-28
FY 2020
Sources
  • 20-F · 2021-04-29
Market Cap$1.9Bcurrent$785.4Mest.$531.9Mest.$474.7Mest.$452.1Mest.
Revenue$303.6M↑14%$266.1M↑60%$166.7M↑60%$104.2M↑5%$99.2M
Operating Income$303.6M↑14%$266.1M↑60%$166.7M↑60%$104.2M↑5%$99.2M
Net Income$205.9M↑24%$166.2M↑81%$92.0M↑47%$62.7M↓1%$63.6M
EPS (Diluted)--$4.55↑79%$2.54↑57%$1.62↑1%$1.60
Gross Margin—————
Operating Margin100.0%100.0%100.0%100.0%100.0%
ROE15.4%↑12%13.8%↑60%8.6%↑36%6.3%↑3%6.1%
Total Debt$4.4B$4.4B↓1%$4.4B↑135%$1.9B↑132%$808.6M
Shareholders' Equity$1.3B↑11%$1.2B↑13%$1.1B↑8%$991.8M↓4%$1.0B
Current Ratio—————
Debt / Equity3.25↓10%3.62↓12%4.13↑118%1.89↑143%0.78
Operating Cash Flow-$122.7M↓112%$1.1B↑238%-$769.7M↑12%-$871.7M↓170%$1.2B
Free Cash Flow-$124.5M↓112%$1.1B↑238%-$771.3M↑12%-$872.2M↓170%$1.2B

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Banking

BLX vs Peers — Financial Grading

Revenue$303.6MBottom 25%
Net Income$205.9MBottom 25%
ROE15.4%Top 25%
D/E3.25Bottom 25%
Op. Margin100.0%Top 25%
Curr. Ratio—
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchPiotroskiDreman
MITSUBISHI UFJ FINANCIAL GROUP INCMUFG$245.7B$21.83$74.2B$10.8B8.8%1.1219.9%—2/71/61/4F-Score 53/9
AMERICAN EXPRESS COAXP$215.0B$320.60$41.3B$10.8B32.4%1.68——2/73/63/4F-Score 43/9
Banco Santander, S.A.SAN$175.9B$12.21—$16.6B12.5%0.02——2/71/62/4F-Score 45/9
BARCLAYS BANK PLCATMP$82.1B$35.04$13.1B$6.3B7.5%0.01——2/71/60/4F-Score 74/9
BARCLAYS PLCBCS$76.0B$22.87$15.0B$9.7B9.2%0.02——1/70/60/4F-Score 72/9
FIRST CITIZENS BANCSHARES INC /DE/FCNCA$25.7B$2324.25$9.5B$2.2B9.9%1.62——5/73/61/4F-Score 52/9
KEYCORP /NEW/KEY$22.7B$21.46$7.5B$1.8B9.0%0.49——2/71/61/4F-Score 64/9
WEBSTER FINANCIAL CORPWBS$12.6B$77.57$2.9B$1.0B10.6%0.0850.7%—2/71/61/4F-Score 72/9